LEADER 00751nam0-22002771i-450-
001 990001716180403321
005 20060927142051.0
035   $a000171618
035   $aFED01000171618
035   $a(Aleph)000171618FED01
035   $a000171618
100   $a20030910d1889----km-y0itay50------ba
101 0 $afre
200 1 $aTraité de la fabrication de l'alcool$fMax Maercker
210   $aLille$cImpr. L. Danel$d1889
215   $a2 v.$d25 cm
610 0 $aAlcoli
676   $a661.82
700  1$aMaercker,$bMax$074027
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990001716180403321
952   $a60 661.82 B 1$b2135/36$fFAGBC
959   $aFAGBC
996   $aTraité de la fabrication de l'alcool$9359063
997   $aUNINA

LEADER 00951nam0 22002651i 450 
001 SUN0015524
005 20060109120000.0
010   $a88-14-08785-7
020   $aIT$b2002 3052
100   $a20040413d2001       |0itac50      ba
101   $aita
102   $aIT
105   $a||||    |||||
200 1 $aOperazioni commerciali via internet$eimpatto sulla gestione amministrativa e fiscale dell'impresa$fGiovanni Mocci
210   $aMilano$cGiuffrè$d[2001]
215   $aVIII, 257 p.$d24 cm.
620   $dMilano$3SUNL000284
676   $a343.4508$v21
700  1$aMocci$b, Giovanni$3SUNV011246$0382767
712   $aGiuffrè$3SUNV001757$4650
801   $aIT$bSOL$c20181231$gRICA
912   $aSUN0015524
950   $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA$d00CONS      XIX.Ec.10                           $e00   19467             20040413            
996   $aOperazioni commerciali via internet$9692528
997   $aUNICAMPANIA

LEADER 01772oam  2200529   450 
001 9910714098603321
005 20220131104947.0
024 8 $a32-387
035   $a(CKB)5470000002506682
035   $a(OCoLC)1202435921$z(OCoLC)1206184780
035   $a(EXLCZ)995470000002506682
100   $a20201030d2020      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aRare diseases $eexpediting treatments for patients : hearing before the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining rare diseases, focusing on expediting treatments for patients, October 3, 2018
210  1$aWashington :$cU.S. Government Publishing Office,$d2020.
215   $a1 online resource (iii, 40 pages)
225 1 $aS. hrg. ;$v115-851
300   $aAccess ID (govinfo): CHRG-115shrg32387.
320   $aIncludes bibliographical references.
517   $aRare diseases 
606   $aRare diseases$xTreatment
606   $aOrphan drugs
606   $aDrug approval
606   $aDrug approval$2fast
606   $aOrphan drugs$2fast
608   $aLegislative hearings.$2fast
608   $aRules.$2fast
608   $aLegislative hearings.$2lcgft
615  0$aRare diseases$xTreatment.
615  0$aOrphan drugs.
615  0$aDrug approval.
615  7$aDrug approval.
615  7$aOrphan drugs.
801  0$bGPO
801  1$bGPO
801  2$bOCLCF
801  2$bOCLCO
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910714098603321
996   $aRare Diseases$91764285
997   $aUNINA